Comparative study of AMP579 and adenosine in inhibition of neutrophil- mediated vascular and myocardial injury during 24 h of reperfusion

Cardiovascular Research

Volumn 47, Issue 2, 2000, Pages 294-305

  Budde, Jason M ^a   Velez, Daniel A ^a   Zhao, Zhi Qing ^a   Clark, Kenneth L ^b   Morris, Cullen D ^a   Muraki, Satoshi ^a   Guyton, Robert A ^a   Vinten Johansen, Jakob ^a  

^a Carlyle Fraser Heart Center   (United States)

^b SANOFI   (France)

Author keywords

Adenosine; Free radicals; Ischemia; Leucocytes

Indexed keywords

4 [7 [[1 [(3 CHLORO 2 THIENYL)METHYL]PROPYL]AMINO] 3H IMIDAZO[4,5 B]PYRIDIN 3 YL] N ETHYL 2,3 DIHYDROXYCYCLOPENTANECARBOXAMIDE; ADENOSINE; CREATINE KINASE; FREE RADICAL; MICROSPHERE; MYELOPEROXIDASE; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY ENDOTHELIUM; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DOG; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART PROTECTION; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ANALYSIS OF VARIANCE; ANIMALS; CELL ADHESION; CELLS, CULTURED; CREATINE KINASE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; IMIDAZOLES; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHILS; PEROXIDASE; PYRIDINES; RANDOM ALLOCATION; RECEPTORS, PURINERGIC P1; REGIONAL BLOOD FLOW; REPERFUSION INJURY; SUPEROXIDES; TIME FACTORS; WATER;

EID: 0033870002     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00115-2     Document Type: Article

References (38)

1. Hearse D.J., Maxwell L., Saldanha C., Gavin J.B. The myocardial vasculature during ischemia and reperfusion: a target for injury and protection. J Mol Cell Cardiol. 25:1993;759-800.
2. Piper H.M., Garcia-Dorado D., Ovize M. A fresh look at reperfusion injury. Cardiovasc Res. 38:1998;291-300.
3. Becker L.C., Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis. 30:1987;23-44.
4. Hearse D.J., Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. [Review]. Cardiovasc Res. 26:1992;101-108.
5. Sluiter W., Pietersma A., Lamers J.M.J., Koster J.F. Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J Cardiovasc Pharmacol. 22:(Suppl 4):1993;S37-S44.
6. Mullane K.M., Read N., Salmon J.A., Moncada S. Role of leukocytes in acute myocardial infarction in anesthetized dogs: Relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Therap. 228:1984;510-522.
7. Dreyer W.J., Smith C.W., Michael L.H., et al. Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium. Circ Res. 65:1989;1751-1762.
8. Dreyer W.J., Michael L.H., West M.W., et al. Neutrophil accumulation in ischemic canine myocardium: Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation. 84:1991;400-411.
9. Albertine K.H., Weyrich A.S., Ma X-L, Lefer D.J., Becker L.C., Lefer A.M. Quantification of neutrophil migration following myocardial ischemia and reperfusion in cats and dogs. J Leukoc Biol. 55:1994;557-566.
10. Kukielka G.L., Hawkins H.K., Michael L., et al. Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. J Clin Invest. 92:1993;1504-1516.
11. Rochitte C.E., Lima J.A.C., Bluemke D.A., et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation. 98:1998;1006-1014.
12. Zhao Z-Q, Nakamura M., Wang N.P. Infarct extension and dynamic coronary endothelial dysfunction in the late reperfusion phase. Circulation. 98:1998;I-796. Abstract.
13. Olafsson B., Forman M.B., Puett D.W., et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation. 76:1987;1135-1145.
14. Pitarys C.J., Virmani R., Vildibill H.D. Jr., Jackson E.K., Forman M.B. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation. 83:1991;237-247.
15. Nichols W.W., Nicolini F.A., Yang B.C., Henson K., Stechmiller J.K., Mehta J.L. Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion. Am Heart J. 127:1994;1201-1211.
16. 2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exp Ther. 280:1997;301-309.
17. Zhao Z-Q, Nakamura M., Wang N-P. Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocytes. Cor Art Dis. 10:1999;617-628.
18. Cronstein B.N., Levin R.I., Belanoff J., Weissmann G., Hirschhorn R. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest. 78:1986;760-770.
19. 2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium. Am J Physiol. 271:1996;H1456-H1464.
20. Simpson P.J., Fantone J.C., Mickelson J.K., Gallagher K.P., Lucchesi B.R. Identification of a time window for therapy to reduce experimental canine myocardial injury: Suppression of neutrophil activation during 72 h of reperfusion. Circ Res. 63:1988;1070-1079.
21. Zannikos P.N., Baybutt R.I., Boutouyrie B.X., Shah B., Hunt T.L., Jensen B.K. Pharmacokinetics, safety, and tolerability of single intravenous infusions of an adenosine agonist, AMP 579, in healthy male volunteers. J Clin Pharmacol. 39:1999;1-9.
22. 2 receptor agonist and cardioprotective. Drug Devel Res. 45:1998;30-43.
23. 2 receptor agonist, AMP 579, in a porcine model of myocardial infarction. J Pharmacol Exp Ther. 268:1998;611-618.
24. 2 receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium. J Cardiovasc Pharmacol. 33:1999;703-710.
25. 2a receptor agonist, induces a delayed protection against myocardial infarction in minipig. Eur J Pharm. 387:2000;101-105.
26. 2A receptor mechanism. Circulation. 100:1999;I-832. Abstract.
27. Cotran R.S., Kumar V., Collins T. Acute and chronic inflammation. Robbins Pathologic Basis of Disease. Sixth Edition :1999;50-88 W.B. Saunders, Philadelphia, PA.
28. Jordan J.E., Zhao Z-Q., Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovas Res. 43:1999;860-878.
29. Mitsos S.E., Fantone J.C., Gallagher K.P., Walden K.M., Simpson P.J., Abrams G.D., Schork M.A., Lucchesi B.R. Canine myocardial reperfusion injury: Protection by a free radical scavenger, N-2-Mercaptopropionyl glycine. J. Cardiovasc. Pharmacol. 8:1986;978-988.
30. Yamazaki T., Seko Y., Tamatani T., et al. Expression of intercellular adhesion molecule-1 in rat heart with ischemia-reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules. Am J Pathol. 143:1993;410-418.
31. Zhao Z-Q, Lefer D.J., Sato H., Hart K.K., Jefforda P.R., Vinten-Johansen J. Monoclonal antibody to ICAM-1 preserves postischemic blood flow and reduces infarct size after ischemia-reperfusion in rabbit. J Leuk Biol. 62:1997;292-300.
32. Bolli R., Zughaib M., Li X.Y. Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial 'stunning'. J Clin Invest. 96:1995;1066-1084.
33. Mullane K., Engler R. Proclivity of activated neutrophils to cause postischemic cardiac dysfunction: Participation in stunning? Cardiovasc Drugs Ther. 5:1991;915-924.
34. Hess M.L., Kukreja R.C. Myocardial stunning. J Card Surg. 9:1994;382-386.
35. Warltier D.C., Auchampach J.A., Gross G.J. Relationship of severity of myocardial stunning to ATP dependent potassium channel modulation. J Card Surg. 8:1993;279-283.
36. Marban E. Pathogenetic role for calcium in stunning? [Review]. Cardiovasc Drugs Ther. 5:1991;891-893.
37. Byrne J.G., Smith W.J., Murphy M.P., Couper G.S., Appleyard R.F., Cohn L.H. Complete prevention of myocardial stunning, contracture, low- reflow, and edema after heart transplantation by blocking neutrophil adhesion molecules during reperfusion. J Thorac Cardiovasc Surg. 104:1992;1589-1596.
38. Smith E.F., Egan J.W., Bugelski P.J., Hillegass L.M., Hill D.E., Griswold D.E. Temporal relation between neutrophil accumulation and myocardial reperfusion injury. Am J Physiol. 255:1988;H1060-H1068.